Literature DB >> 17724897

A cocaine-associated quadriplegia and motor aphasia after first use of cocaine.

Jacek Sein Anand1, Zygmunt Chodorowski, Marek Wiśniewski, Agnieszka Gólska.   

Abstract

UNLABELLED: A 31-year-old female who have snorted one "line" of cocaine hydrochloride (approximately 35 mg), for the first time in her life, was admitted to the hospital because of acute onset of right hemiplegia and left hemiparesis evolving into quadriplegia. Motor aphasia, right eye-ball divergent strabismus and right mouth recess lowering were also observed.
CONCLUSIONS: A first time mucosal administration of cocaine hydrochloride even in low dose can cause severe neurological complications like quadriplegia and aphasia. Cocaine-associated stroke can be a diagnostic problem in the emergency room. Unconscious patients or those with acute onset of neurological disorders can form a real diagnostic challenge, especially when there is no evidence of previous drug taking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724897

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  3 in total

1.  Acute Spinal Cord Ischemia Associated With Cocaine Use: A Case Report.

Authors:  Ramya Akella; Rishi Raj; Lakshmi Kannan; Aasems Jacob; Subramanya Shyam Ganti
Journal:  Cureus       Date:  2022-06-06

Review 2.  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse.

Authors:  Aristides Tsatsakis; Anca Oana Docea; Daniela Calina; Konstantinos Tsarouhas; Laura-Maria Zamfira; Radu Mitrut; Javad Sharifi-Rad; Leda Kovatsi; Vasileios Siokas; Efthimios Dardiotis; Nikolaos Drakoulis; George Lazopoulos; Christina Tsitsimpikou; Panayiotis Mitsias; Monica Neagu
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

Review 3.  Effect of drug use in the treatment of acute ischemic stroke: A scoping review.

Authors:  Nisha Dabhi; Panagiotis Mastorakos; Jennifer D Sokolowski; Ryan T Kellogg; Min S Park
Journal:  Surg Neurol Int       Date:  2022-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.